PMID- 29114461 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 2215-0013 (Print) IS - 2215-0013 (Electronic) IS - 2215-0013 (Linking) VI - 2 IP - 4 DP - 2015 Dec TI - The search for new biomarkers for cognition in schizophrenia. PG - 172-178 LID - 10.1016/j.scog.2015.10.004 [doi] AB - The search for biomarkers in cognition has been the focus of a large part of the research on patients suffering from schizophrenia. The scientific literature is heterogeneous, and few studies establishing an integrative model of pathogenesis and therapeutic response are available in this field. In this review, we aimed to summarize three essential aspects correlated with cognitive performance: 1) the relationship between inflammation and cognition in schizophrenia, 2) the role of prolactin in cognition, and 3) the association between cognition and neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF). Several studies support the association of inflammatory markers with cognitive status in schizophrenia. In recent decades, the development of effective therapies for cognitive impairment in schizophrenia has focused on the search for anti-inflammatory and immunomodulatory medications. Conversely, the implications of prolactin and its functions in cognition, the transition to psychosis and the diagnosis and prognosis of schizophrenia have been established independent of antipsychotic treatment. With regard to neurotrophic factors, a recent study has correlated BDNF levels with cognitive recovery in schizophrenic patients treated with cognitive remediation. We conclude that although there is a diversity of biomarkers focused on cognitive function in schizophrenia, BDNF is the biomarker that has accumulated the vast majority of evidence in the current literature. FAU - Penades, Rafael AU - Penades R AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Hospital Clinic Barcelona. AD - University of Barcelona. AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS). AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). FAU - Garcia-Rizo, Clemente AU - Garcia-Rizo C AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Hospital Clinic Barcelona. AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS). AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). FAU - Bioque, Miquel AU - Bioque M AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Hospital Clinic Barcelona. AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). FAU - Gonzalez-Rodriguez, Alexandre AU - Gonzalez-Rodriguez A AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Hospital Clinic Barcelona. FAU - Cabrera, Bibiana AU - Cabrera B AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). FAU - Mezquida, Gisela AU - Mezquida G AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). FAU - Bernardo, Miquel AU - Bernardo M AD - Barcelona Clinic Schizophrenia Unit (BCSU). AD - Hospital Clinic Barcelona. AD - University of Barcelona. AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS). AD - Centro de Investigacion en Red de Salud Mental (CIBERSAM). LA - eng PT - Journal Article PT - Review DEP - 20151217 PL - United States TA - Schizophr Res Cogn JT - Schizophrenia research. Cognition JID - 101632223 PMC - PMC5609637 OTO - NOTNLM OT - BDNF OT - Biomarkers OT - Cognition OT - Inflammation OT - Prolactin OT - Schizophrenia EDAT- 2015/12/17 00:00 MHDA- 2015/12/17 00:01 PMCR- 2015/12/17 CRDT- 2017/11/09 06:00 PHST- 2017/11/09 06:00 [entrez] PHST- 2015/12/17 00:00 [pubmed] PHST- 2015/12/17 00:01 [medline] PHST- 2015/12/17 00:00 [pmc-release] AID - S2215-0013(15)00033-5 [pii] AID - 10.1016/j.scog.2015.10.004 [doi] PST - epublish SO - Schizophr Res Cogn. 2015 Dec 17;2(4):172-178. doi: 10.1016/j.scog.2015.10.004. eCollection 2015 Dec.